BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 16258107)

  • 1. Opportunities for targeted therapies in hepatocellular carcinoma.
    Thomas MB; Abbruzzese JL
    J Clin Oncol; 2005 Nov; 23(31):8093-108. PubMed ID: 16258107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be?
    Zhu AX
    Oncologist; 2006; 11(7):790-800. PubMed ID: 16880238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hepatocellular carcinoma.
    Blum HE
    Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):129-45. PubMed ID: 15757809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference-mediated prevention and therapy for hepatocellular carcinoma.
    Romano PR; McCallus DE; Pachuk CJ
    Oncogene; 2006 Jun; 25(27):3857-65. PubMed ID: 16799627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment options for hepatocellular carcinoma.
    Sandhu DS; Tharayil VS; Lai JP; Roberts LR
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):81-92. PubMed ID: 19072372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatocellular carcinoma: novel molecular aspects for differential diagnosis and therapy].
    Kern MA; Schirmacher P
    Verh Dtsch Ges Pathol; 2006; 90():85-98. PubMed ID: 17867584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hepatocellular carcinoma.
    Yu AS; Keeffe EB
    Rev Gastroenterol Disord; 2003; 3(1):8-24. PubMed ID: 12684589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hepatocellular carcinoma.
    Forner A; Hessheimer AJ; Isabel Real M; Bruix J
    Crit Rev Oncol Hematol; 2006 Nov; 60(2):89-98. PubMed ID: 16860993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New therapies for hepatocellular carcinoma.
    Avila MA; Berasain C; Sangro B; Prieto J
    Oncogene; 2006 Jun; 25(27):3866-84. PubMed ID: 16799628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palliative treatment in advanced hepatocellular carcinoma: has it made any difference?
    Paul SB; Manjunatha YC; Acharya SK
    Trop Gastroenterol; 2009; 30(3):125-34. PubMed ID: 20306740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic therapy for hepatocellular carcinoma.
    Thomas MB
    Cancer J; 2008; 14(2):123-7. PubMed ID: 18391618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma (HCC): current and evolving therapies.
    Gish RG; Baron A
    IDrugs; 2008 Mar; 11(3):198-203. PubMed ID: 18311657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatocellular carcinoma--epidemiology and treatment].
    Małkowski P; Pacholczyk M; Łagiewska B; Adadyński L; Wasiak D; Kwiatkowski A; Chmura A; Czerwiński J
    Przegl Epidemiol; 2006; 60(4):731-40. PubMed ID: 17682755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma: current management and recent advances.
    Lau WY; Lai EC
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):237-57. PubMed ID: 18522878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical resection of hepatocellular carcinoma.
    Duffy JP; Hiatt JR; Busuttil RW
    Cancer J; 2008; 14(2):100-10. PubMed ID: 18391615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study.
    El-Serag HB; Siegel AB; Davila JA; Shaib YH; Cayton-Woody M; McBride R; McGlynn KA
    J Hepatol; 2006 Jan; 44(1):158-66. PubMed ID: 16290309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States.
    Marrero JA; Fontana RJ; Su GL; Conjeevaram HS; Emick DM; Lok AS
    Hepatology; 2002 Dec; 36(6):1349-54. PubMed ID: 12447858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of hepatocellular carcinoma and molecular therapies.
    Mínguez B; Tovar V; Chiang D; Villanueva A; Llovet JM
    Curr Opin Gastroenterol; 2009 May; 25(3):186-94. PubMed ID: 19387255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined approach to hepatocellular carcinoma: a new treatment concept for nonresectable disease.
    Strebel BM; Dufour JF
    Expert Rev Anticancer Ther; 2008 Nov; 8(11):1743-9. PubMed ID: 18983234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
    Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.